Uptick Newswire this morning released an interview on its “Stock Day” Podcast with Richard T. Schumacher, president and CEO of Pressure BioSciences (OTCQB: PBIO). PBIO is a global life sciences company with three unique, patent protected technology platforms. Among other highlights from the interview, Schumacher discussed the company’s patented technology platform called Ultra Sheer Technology (“UST”). UST is comprised of putting liquids under pressure and then releasing the liquid material while still under pressure through a series of valves. This process kills bacteria or viruses in the liquid, allowing it to sit at room temperature for extended periods of time. “We believe that UST has the potential of delivering to consumers liquid food products that actually look and taste good while having a longer shelf life without preservatives or refrigeration. Additionally, UST processing offers potential applications that go well beyond food to include pharmaceuticals and nutraceuticals and other items such as lubricants, paints, and cosmetics,” Pressure BioSciences president and CEO Richard T. Schumacher stated in the interview.
To listen to the full interview, visit http://ibn.fm/ai3ic
To view the full press release, visit http://ibn.fm/3XGw9
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.